Please Login to read the full article.
Clinica
Medtech regulatory debate needs to tackle risk/benefit of aesthetic vs medical products
19 January 2012
Amanda Maxwell
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Delay likely for EU medtech directive recast draft as proposed revisions undergo stress testing
- Post-PIP EU Parliament resolution plan likely to call for premarket authorisation system: how will the commission react?
- Howe report finds EU medtech adverse incident reporting fails on safety: registries needed
- European Parliament call for premarket approval is not a done deal, says Eucomed's Brennan
Other Informa News
EVENTS
